Chad A Livasy Selected Research

Chad A Livasy Research Topics

Disease

23	Neoplasms (Cancer) 11/2022 - 01/2003
19	Breast Neoplasms (Breast Cancer) 12/2022 - 03/2003
5	Carcinoma (Carcinomatosis) 01/2023 - 12/2004
4	Residual Neoplasm 12/2022 - 11/2022
3	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2015 - 11/2004
3	Inflammation (Inflammations) 09/2008 - 01/2008
2	Triple Negative Breast Neoplasms 12/2022 - 12/2013
2	Neoplasm Metastasis (Metastasis) 12/2004 - 01/2003
1	Carcinoma in Situ 01/2019
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 02/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Adenocarcinoma 05/2015
1	Disease Susceptibility (Diathesis) 09/2008
1	Infarction (Infarctions) 06/2008
1	Thrombosis (Thrombus) 06/2008
1	Lymphatic Metastasis 10/2007
1	Carcinosarcoma 01/2006
1	Hypersensitivity (Allergy) 01/2005
1	Hyperplasia 12/2004
1	Carcinogenesis 11/2004
1	Clear Cell Adenocarcinoma 06/2004
1	Colorectal Neoplasms (Colorectal Cancer) 01/2003

Drug/Important Bio-Agent (IBA)

6	ErbB Receptors (EGF Receptor)IBA 11/2022 - 01/2006
6	ParaffinIBA 01/2018 - 01/2003
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2009
5	Estrogen ReceptorsIBA 05/2015 - 02/2006
5	Phenobarbital (Luminal)FDA Link 02/2014 - 02/2006
5	Proteins (Proteins, Gene)FDA Link 12/2013 - 01/2003
5	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2009 - 01/2003
5	Formaldehyde (Formol)FDA Link 06/2009 - 01/2003
4	Phosphotransferases (Kinase)IBA 01/2023 - 03/2003
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2005 - 01/2003
3	Hormones (Hormone)IBA 12/2022 - 05/2015
3	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 02/2006
2	human ERBB2 proteinIBA 12/2022 - 06/2009
2	Lapatinib (GW572016)FDA Link 01/2012 - 06/2010
2	AntibodiesIBA 05/2008 - 01/2006
2	Keratin-5 (Keratin 5)IBA 02/2007 - 02/2006
2	Estrogens (Estrogen)FDA Link 10/2005 - 01/2005
2	Messenger RNA (mRNA)IBA 12/2004 - 01/2003
1	tyrosine receptor (receptor, tyrosine)IBA 01/2023
1	NeurotensinIBA 01/2019
1	Neurofibromin 1 (Neurofibromin)IBA 02/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Hematoxylin (Haematoxylon)IBA 12/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2014
1	MicroRNAs (MicroRNA)IBA 02/2014
1	mouse MIRN29 microRNAIBA 02/2014
1	ClaudinsIBA 12/2013
1	MethyltransferasesIBA 12/2013
1	EnzymesIBA 12/2013
1	Complementary DNA (cDNA)IBA 06/2009
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2009
1	ChromatinIBA 09/2008
1	FibrinIBA 06/2008
1	Factor VIII (Coagulation Factor VIII)IBA 05/2008
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 05/2008
1	WD repeat containing planar cell polarity effectorIBA 05/2008
1	Janus Kinase 3IBA 05/2008
1	Cystatin MIBA 10/2007
1	hydrogen sulfite (bisulfite)IBA 10/2007
1	Epidermal Growth Factor (EGF)IBA 06/2006
1	Keratin-8 (Keratin 8)IBA 02/2006
1	VimentinIBA 02/2006
1	Tyrosine (L-Tyrosine)FDA Link 01/2006
1	Progesterone FDA LinkGeneric 10/2005
1	Lysine (L-Lysine)FDA Link 01/2005
1	Amino Acids FDA Link 01/2005
1	NucleotidesIBA 01/2005
1	Estrogen Receptor alphaIBA 01/2005
1	Arginine (L-Arginine)FDA Link 01/2005
1	Codon (Codons)IBA 01/2005
1	Diethylstilbestrol (Stilbestrol)FDA Link 06/2004
1	Protein Kinases (Protein Kinase)IBA 03/2003
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2003

Therapy/Procedure

4	Neoadjuvant Therapy 12/2022 - 11/2022
4	Therapeutics 12/2013 - 01/2006
4	Radiotherapy 04/2011 - 02/2007
3	Segmental Mastectomy (Lumpectomy) 04/2011 - 02/2007
1	Cytoreduction Surgical Procedures 01/2018
1	Adjuvant Chemotherapy 01/2018
1	Mammaplasty (Breast Reconstruction) 02/2014
1	Drug Therapy (Chemotherapy) 01/2012
1	Simple Mastectomy 04/2011
1	Lasers (Laser) 05/2008
1	Cesarean Section (Caesarean Section) 01/2008
1	Mastectomy (Mammectomy) 02/2007
1	Aftercare (After-Treatment) 06/2004